CIK: 0001534261 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,199,325 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 3,007,164 | $323,992 | 27.0% | $9.11 | +1095.5% | COM CL A | 81663L200 |
| BLFS | BIOLIFE SOLUTIONS INC | 6,707,165 | $171,100 | 14.3% | $19.43 | +22.1% | COM NEW | 09062W204 |
| RVMD | REVOLUTION MEDICINES INC | 2,647,333 | $123,630 | 10.3% | $25.89 | +51.2% | COM | 76155X100 |
| LAB | STANDARD BIOTOOLS INC | 77,558,856 | $100,827 | 8.4% | $2.28 | -42.6% | COM | 34385P108 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,780,000 | $77,555 | 6.5% | $14.11 | +186.6% | COM | 05370A108 |
| RLAY | RELAY THERAPEUTICS INC | 11,341,381 | $59,202 | 4.9% | $16.30 | -76.6% | COM | 75943R102 |
| ILMN | ILLUMINA INC | 525,000 | $49,859 | 4.2% | $116.47 | -14.8% | COM | 452327109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,555,000 | $43,540 | 3.6% | $28.16 | — | SPONSORED ADS | 86366E106 |
| BEAM | BEAM THERAPEUTICS INC | 1,600,000 | $38,832 | 3.2% | $36.48 | -45.5% | COM | 07373V105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 55,000 | $25,080 | 2.1% | $138.08 | +194.9% | COM | 02043Q107 |
| TEM | TEMPUS AI INC | 294,127 | $23,739 | 2.0% | $70.04 | 0.0% | CL A | 88023B103 |
| NGNE | NEUROGENE INC | 1,295,361 | $22,449 | 1.9% | $27.94 | -28.1% | COM | 64135M105 |
| MAZE | MAZE THERAPEUTICS INC | 758,857 | $19,677 | 1.6% | $12.04 | +40.2% | COM | 578784100 |
| PRME | PRIME MEDICINE INC | 3,167,175 | $17,546 | 1.5% | $4.73 | -14.1% | COM | 74168J101 |
| SPRY | ARS PHARMACEUTICALS INC | 1,600,000 | $16,080 | 1.3% | $14.35 | 0.0% | COM | 82835W108 |
| HIMS | HIMS & HERS HEALTH INC | 230,000 | $13,046 | 1.1% | $38.20 | +34.1% | COM CL A | 433000106 |
| DNLI | DENALI THERAPEUTICS INC | 890,000 | $12,923 | 1.1% | $29.48 | -51.3% | COM | 24823R105 |
| SEPN | SEPTERNA INC | 553,268 | $10,407 | 0.9% | $23.65 | -44.5% | COM | 81734D104 |
| VCYT | VERACYTE INC | 276,308 | $9,486 | 0.8% | $24.40 | +17.6% | COM | 92337F107 |
| UNH | UNITEDHEALTH GROUP INC | 25,000 | $8,633 | 0.7% | $298.94 | 0.0% | COM | 91324P102 |
| INCY | INCYTE CORP | 100,000 | $8,481 | 0.7% | $79.04 | 0.0% | COM | 45337C102 |
| GH | GUARDANT HEALTH INC | 100,000 | $6,248 | 0.5% | $26.87 | +102.5% | COM | 40131M109 |
| EXAS | EXACT SCIENCES CORP | 90,000 | $4,924 | 0.4% | $74.77 | -33.2% | COM | 30063P105 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282,312 | $3,269 | 0.3% | $11.58 | — | COM NEW | 107924102 |
| ABSI | ABSCI CORPORATION | 973,260 | $2,959 | 0.2% | $19.41 | -85.8% | COM | 00091E109 |
| CTNM | CONTINEUM THERAPEUTICS INC | 148,333 | $1,743 | 0.1% | $16.10 | -49.9% | CL A | 21217B100 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 723,767 | $926 | 0.1% | $11.43 | -88.2% | COM | 69404D108 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $807 | 0.1% | $6.72 | -21.9% | CL A | 75629V104 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 86,014 | $637 | 0.1% | $20.37 | -74.0% | COM | 61225M102 |
| IPSC | CENTURY THERAPEUTICS INC | 1,228,190 | $612 | 0.1% | $10.97 | -95.1% | COM | 15673T100 |
| TNYA | TENAYA THERAPEUTICS INC | 361,969 | $586 | 0.0% | $12.86 | -92.2% | COM | 87990A106 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $532 | 0.0% | $10.02 | +19.4% | CL A NEW | 37611X209 |